David C. Myles SEC EDGAR Filings (CIK 0001831216)

SEC EDGAR filings, ownership reports, and insider transactions for David C. Myles.

Business address
C/O Olema Pharmaceuticals, Inc., 512 2 Nd Street, 4 Th Floor, San Francisco, CA, 94107
Top holdings (ownership)
OLMA
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
David C. Myles has filed 28 SEC EDGAR filings since 18 Nov 2020

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 14 Jan 2026 12 Jan 2026 001-39712
144 Open Document Open Filing 14 Jan 2026
144 Open Document Open Filing 13 Jan 2026
144 Open Document Open Filing 12 Jan 2026
4 Open Document Open Filing 23 Dec 2025 19 Dec 2025 001-39712
144 Open Document Open Filing 19 Dec 2025
4 Open Document Open Filing 03 Mar 2025 28 Feb 2025 001-39712
4 Open Document Open Filing 11 Dec 2024 09 Dec 2024 001-39712
144 Open Document Open Filing 11 Dec 2024
144 Open Document Open Filing 10 Dec 2024
4 Open Document Open Filing 05 Feb 2024 01 Feb 2024 001-39712
4 Open Document Open Filing 22 Nov 2023 20 Nov 2023 001-39712
144 Open Document Open Filing 22 Nov 2023
144 Open Document Open Filing 21 Nov 2023
4 Open Document Open Filing 13 Nov 2023 08 Nov 2023 001-39712
144 Open Document Open Filing 08 Nov 2023
4 Open Document Open Filing 03 Nov 2023 01 Nov 2023 001-39712
144 Open Document Open Filing 03 Nov 2023
144 Open Document Open Filing 02 Nov 2023
144 Open Document Open Filing 01 Nov 2023
4 Open Document Open Filing 21 Sep 2023 19 Sep 2023 001-39712
144 Open Document Open Filing 19 Sep 2023
4 Open Document Open Filing FORM 4 SUBMISSION 02 Feb 2023 01 Feb 2023 001-39712
4 Open Document Open Filing 03 Feb 2022 01 Feb 2022 001-39712
4 Open Document Open Filing 14 Dec 2021 10 Dec 2021 001-39712
4 Open Document Open Filing FORM 4 SUBMISSION 23 Nov 2020 23 Nov 2020 001-39712
4 Open Document Open Filing FORM 4 SUBMISSION 19 Nov 2020 15 Jun 2020 001-39712
3 Open Document Open Filing FORM 3 SUBMISSION 18 Nov 2020 18 Nov 2020 001-39712